Scienza e Tecnologia
Almirall announces Gianfranco Nazzi as new CEO
BARCELONA, Spain , Feb. 3, 2021 /PRNewswire/ -- Almirall, S.A. (BME: ALM), a global biopharmaceutical company focused on Medical Dermatology based in Barcelona, announced today that the Board of Directors have approved the appointment of Mr. Gianfranco Nazzi as CEO and Executive Director of the Board of Directors effective May 1, 2021 .
Mr. Nazzi joins Almirall from Teva Pharmaceuticals Industries Ltd, where he has most recently been serving as Executive Vice President of the International Markets Region and as a member of the Teva Executive Committee. While at Teva over the past seven years, he has held roles of increasing responsibility and geographic scope based in Israel and the Netherlands . He held the position of Senior Vice President Specialty Medicines Europe and President and CEO Growth Markets Region. Prior to Teva, Mr. Nazzi held a variety of senior positions in Astra Zeneca, GSK and Eli Lilly in commercial and General Management roles based in the UK, Italy , Serbia and the US.
" said
, Chairman of the Board and President of Almirall.
stated
Gianfranco Nazzi is Italian and holds a degree in Economics and Banking Sciences from the University of Udine and a Master's Degree of Business Administration from the Bocconi University of Milan.
Mr. Nazzi will take over the CEO duties from Mike McClellan , who at the beginning of the year was appointed interim CEO in addition to his role as CFO after the company's former Chief Executive Officer, Peter Guenter , left Almirall on December 31 to pursue other professional endeavors.
Logo: https://mma.prnewswire.com/media/1217694/Almirall_Logo.jpg